Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are by far the most maturely designed TPD techniques. On this evaluate, we deal with both preclinical experiments and clinical trials to provide an extensive summary of the security and clinical efficiency of PROTACs and MGDs in hematologic malignancies over the past 20